White label ELPA - ClinicalTrials.eu

Study of 64Cu-DOTATATE and 18F-FDG PET/CT imaging to predict disease progression in patients with neuroendocrine neoplasms

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on Hydroxycarbamide Tablets for Children with Sickle Cell Disease

Recruiting

2 1 1
Investigated diseases:
- Sickle cell disease
Investigated drugs:
- Hydroxycarbamide
Study on Long-term Safety of Weekly Intravenous Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1-Antitrypsin Deficiency

Recruiting

3 1 1 1
Investigated diseases:
- Emphysema
Investigated drugs:
- Alpha-1-Proteinase Inhibitor (Human)
Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

Recruiting

3 1 1 1
Investigated diseases:
- Bacterial prostatitis
Investigated drugs:
Study on Oxygen Therapy to Reduce Postoperative Complications in At-Risk Ankle Trauma Surgery Patients

Recruiting

3 1 1 1
Investigated diseases:
- Tissue anoxia
Investigated drugs:
- Oxygen
Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

Recruiting

3 1 1
Investigated diseases:
- C3 glomerulopathy
Investigated drugs:
- Iptacopan
- Iptacopan Hydrochloride
+1
Study on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn’s Disease

Recruiting

3 1 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
Study on Personalized Maintenance Therapy with Rituximab and Corticosteroids for Patients with Pemphigus

Recruiting

3 1 1 1
Investigated diseases:
- Pemphigus
Investigated drugs:
- Rituximab
Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

Recruiting

2 1 1 1
Investigated diseases:
- BRAF gene mutation
Investigated drugs:
- (3R)-N-[3-[5-(2-Cyclopropylpyrimidin-5-Yl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl]-2,4-Difluorophenyl]-3-Fluoropyrrolidine-1-Sulfonamide
- Cobicistat
+1
Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

Recruiting

3 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies